In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-04-04
DOI
10.1111/dom.14706
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes
- (2022) Julia Ware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed ™ 670G system trial
- (2022) Gregory P. Forlenza et al. PEDIATRIC DIABETES
- A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
- (2021) Richard M Bergenstal et al. LANCET
- Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes
- (2021) Olivia J. Collyns et al. DIABETES CARE
- The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes
- (2021) Peter Gerhardsson et al. Diabetes Technology & Therapeutics
- Predictors of Time-in-Range (70–180 mg/dL) Achieved Using a Closed-Loop Control System
- (2021) Melissa J. Schoelwer et al. Diabetes Technology & Therapeutics
- The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2021) Richard I.G. Holt et al. DIABETES CARE
- The automated pancreas: A review of technologies and clinical practice
- (2021) Torben Biester et al. DIABETES OBESITY & METABOLISM
- Diabetesberatung zum Hybrid-AID-System bei Typ-1-Diabetes: neue Perspektiven und Therapieempfehlungen
- (2020) Torben Biester et al. Diabetologie und Stoffwechsel
- The Efficacy and Safety of Insulin Pump Therapy with Predictive Low Glucose Suspend Feature in Decreasing Hypoglycemia in Children with Type 1 Diabetes Mellitus: a systematic review and meta‐analysis
- (2020) Ahlam Alotaibi et al. PEDIATRIC DIABETES
- One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes
- (2020) Goran Petrovski et al. ACTA DIABETOLOGICA
- A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
- (2020) Marc D. Breton et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes
- (2020) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers
- (2020) Laya Ekhlaspour et al. Diabetes Technology & Therapeutics
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial
- (2019) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial
- (2019) Martin Tauschmann et al. DIABETES CARE
- Reduced burden of diabetes and improved quality of life: experiences from unrestricted day‐and‐night hybrid closed‐loop use in very young children with type 1 diabetes
- (2019) Gianluca Musolino et al. PEDIATRIC DIABETES
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery
- (2019) Klemen Dovc et al. DIABETES CARE
- Efficacy and Safety of Real-Life Usage of MiniMed 670G Automode in Children with Type 1 Diabetes Less than 7 Years Old
- (2019) Parisa Salehi et al. Diabetes Technology & Therapeutics
- Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months
- (2019) Laurel H. Messer et al. PEDIATRIC DIABETES
- Assessment and management of hypoglycemia in children and adolescents with diabetes
- (2018) Mary B Abraham et al. PEDIATRIC DIABETES
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
- (2018) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Future Acceptance of an Artificial Pancreas in Adults with Type 1 Diabetes
- (2011) Arianne C. van Bon et al. Diabetes Technology & Therapeutics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started